The condition affects adults primarily older than 65. Though Parkinson’s disease itself is separated into five stages, Parkinson’s disease dementia isn’t as well understood. People with ...

Severe, debilitating symptoms mark end-stage Parkinson's dementia. Worsening sleep problems and frequent hallucinations tend to occur, and individuals can become extremely confused, depressed ...

Interim Analysis Expected End of 2Q 2025 BETHESDA, MD / ACCESS Newswire / March 14, 2025 / Gain Therapeutics, Inc. (Nasdaq:GANX) ...

By establishing a metric to quantify brain changes associated with the stages of Parkinson's disease, the study could have several implications. Starting with supporting better diagnosis.

By establishing a metric to quantify brain changes associated with the stages of Parkinson's disease, the study could have several implications, starting with supporting a better diagnosis.

Annovis Bio Inc. (NYSE: ANVS) ("Annovis"), a late-stage clinical drug platform company pioneering transformative therapies ...

Polish drugmaker Celon Pharma (WSE: CLN) has announced positive results from a Phase II trial of CPL’36, an experimental oral ...

Biogen is continuing to thin its pipeline, dropping a phase 2 program acquired in the $7.3 billion Reata Pharmaceuticals buyout and kicking early-stage Alzheimer’s and Parkinson’s prospects ...